1991
DOI: 10.1016/s0272-2712(18)30540-7
|View full text |Cite
|
Sign up to set email alerts
|

The Influence of HIA and ABO Antigens on Graft Rejection and Survival

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

1991
1991
2018
2018

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 74 publications
0
3
0
Order By: Relevance
“…Generally, ABO‐mismatch and disparity in MHC surface antigens are well‐known to influence outcomes of transplanted tissues resulting in their use as predictors for allograft survival . In liver transplantation, however, positive cross‐matches appear more relevant than MHC or even ABO compatibility, highlighting the organ's tolerogenic properties .…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Generally, ABO‐mismatch and disparity in MHC surface antigens are well‐known to influence outcomes of transplanted tissues resulting in their use as predictors for allograft survival . In liver transplantation, however, positive cross‐matches appear more relevant than MHC or even ABO compatibility, highlighting the organ's tolerogenic properties .…”
Section: Discussionmentioning
confidence: 99%
“…Generally, ABO-mismatch and disparity in MHC surface antigens are well-known to influence outcomes of transplanted tissues resulting in their use as predictors for allograft survival. (31)(32)(33) In liver transplantation, however, positive cross-matches appear more relevant than MHC or even ABO compatibility, highlighting the organ's tolerogenic properties. (34) Despite this behavior in solid organ transplantation, our experiments with different allogeneic responder PBMCs in coculture with the same PHHs or vice versa led to broad variation of proliferative outcomes, although correlation with the degree of HLA matching was still not observed.…”
Section: Discussionmentioning
confidence: 99%
“…[3][4][5][6][7][8] Despite the use of such therapeutic methods, graft survival in ABO-incompatible organ transplantation is generally inferior compared with that in ABO-compatible transplantation because of the reappearance of anti-A/B Abs. 1,4,[9][10][11][12] The specific and persistent inhibition of anti-A/B Ab production might be necessary for completely preventing anti-A/B Ab-mediated rejection; however, a method for either elimination or suppression of B-cell clones responding to the A/B carbohydrates has not yet been established.…”
Section: Introductionmentioning
confidence: 99%